Physician profile
Lisa M Mofle
NPI 1710961511
$206.20
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.08 · 2021: $12.71 · 2022: $32.39 · 2023: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $133.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $32.16 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $28.54 | 2022-2023 | Rybelsus, Ozempic |
| Amgen INC. | $28.08 | 2019 | |
| Mylan Specialty L.P. | $26.60 | 2021-2023 | Yupelri |
| Pfizer INC. | $20.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.81 | 2023 | Leqvio |
| Philips North America LLC | $14.61 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.66 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.64 | 2023 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $13.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Mofle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.